We identified candidate biomarkers of induced anti-tumor immunity in breast cancer by performing a literature review focused on protein-level probes that were previously associated with ICD induction; high TILs, including CD8 T cells; inflammatory responses; and/or the response to ICB. Here, CD8A is linked to neoplasm.